enVVeno Medical (NVNO)
(Delayed Data from NSDQ)
$5.20 USD
+0.15 (2.97%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $5.19 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
NVNO 5.20 +0.15(2.97%)
Will NVNO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVNO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NVNO
enVVeno (NVNO) Plans to Expedite enVVe Development for CVI
NVNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NVNO
enVVeno Medical reports Q2 results
enVVeno Medical reports Q2 EPS (31c) vs. (58c) last year
enVVeno Medical expects capital to fund company through several milestones
enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series